The results of third phase trials of India's first indigenously developed #COVID19Vaccine Covaxin are expected to be released next month.#Covaxin manufacturer @BharatBiotech said its service provider, IQVIA, has started final statistical analysis. pic.twitter.com/aBCwwCkn65— IANS Tweets (@ians_india) June 10, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


